blog

Getting Patients to “See” Your Clinical Trial Advertising

By Justin Jones on Tue, Apr 25, 2017 | 3 min read

Name something that happens to you five times every waking minute. Give up? It’s advertisements. The average person is exposed to approximately five ad messages every minute, for a total of about 3000 to 5000 advertisements a day. From TV and radio commercials to surfing the web to walking around your local grocery store, the flood of advertisements trying to grab your attention has never been greater. So here are two questions I want you to consider: how many of those ads do you remember and did they motivate you to take action? 

Topics: Patient Recruitment, advertising, clinical trials

New eBook: Rare Disease Research. What’s Next?

By BBK on Thu, Feb 23, 2017 | 2 min read

Nearly a year ago, we released our first guide on rare disease clinical research. In it, we were looking to address some important questions facing the people who are committed to improving the lives of patients with rare disorders. While much progress has been made, it is critical that those of us in the health care and life sciences industry remain keenly aware of all that’s being done to further research and improve outcomes. In our latest eBook, “Focus 5: Rare Disease Research. What’s Next?” we reached out to industry experts for their insights on this evolving clinical research landscape.

Topics: Patient Recruitment, Patient Engagement, Rare Disease, clinical research

The Importance of Advocacy Outreach for Patient Recruitment

By Aaron Fleishman on Tue, Aug 25, 2015 | 3 min read

Partnering with advocacy groups is a vital component to any clinical trial outreach effort. The approach to working with advocacy groups has changed in recent years. It is not just about the one connection you may have with one organization. These days it’s about working with the condition community as a whole for one common goal. Advocacy groups often have direct connections to people affected by a condition and can be highly beneficial to enrollment throughout the patient recruitment process.

Topics: Patient Recruitment, Patient Advocacy

The Keys to Future Patient Recruitment Success

By BBKWorldwide on Fri, Aug 21, 2015 | 3 min read

At the 2015 DIA Annual Meeting this past June there was a lot of talk about how technology is impacting the way we interact with patients, sites, and other key players in the clinical study landscape. When I sat down with three other industry experts to discuss bringing clinical trial practices into the 21st century, I shifted the talk to focus on the forces that drive the way we communicate with patients and with each other within our industry. Furthermore, how can we look at today’s trends to better predict the future of patient recruitment and engagement?

Topics: Patient Recruitment

Social Media Listening to Support Patient Recruitment

By Aaron Fleishman on Tue, Jul 28, 2015 | 2 min read

Pew Research Center indicates that 87 percent of Americans are using the Internet regularly.  With social and digital media becoming ever-more prevalent, it makes sense that within the clinical trial industry, researchers are now looking to it as a way to control some of the escalating R&D costs and make the process more patient-centric.

Topics: Patient Recruitment, Social Media

Analyze Investigator Resources When Recruiting for Rare Disease

By Maria Cipicchio on Wed, Jul 1, 2015 | 3 min read

As we discussed in part I of our blog series on adaptive patient recruitment, the rare disease community is constantly striving to invest in developing new treatments. While there is a huge unmet need in this area, there are recruitment tactics that effectively provide support. Beyond the introduction of an early support program, which Jaime Cohen discussed in our previous post, there are additional strategies that can assist in higher recruitment numbers for rare disease. In part II of our series on rare disease we explore further.

Topics: Patient Recruitment, Rare Disease

Content Marketing Strategies to Support Patient Recruitment

By Jay Housman on Thu, Jun 25, 2015 | 3 min read

The average person spends nearly 4.4 hours of leisure time in front of screens each day. People are online, on their phones or using their tablets in increasing amounts. Given this statistic, it seems natural for there to be a shift from native advertising to content marketing. It’s best to reach consumers where they already are and to push relevant content to them directly to pique interest.

Topics: Patient Recruitment, Content Marketing

MassBio Forum Insights: Clinical Trials in the Age of Social Media

By Aaron Fleishman on Tue, Jun 23, 2015 | 3 min read

We know that social media usage is up year-over-year across all ages, but how is it being put to use for clinical research? On June 11th I had the pleasure of participating in a social media forum hosted by MassBio with PatientsLikeMe, Biogen and Boston Children’s Hospital. It was an eye opening discussion that looked at the use of social media within clinical trials from the varying perspectives of advocacy groups, IRBs and pharmaceutical companies, each with different goals in mind and facing their own set of unique challenges.

Topics: Patient Recruitment, Social Media

Adaptive Patient Recruitment for Rare Disease: Early Support is Key

By BBKWorldwide on Wed, Jun 3, 2015 | 3 min read

There is a huge unmet need in the rare disease community to invest in developing treatments. According to the US advocacy group Global Genes, there are more than 7,000 distinct rare diseases affecting 350,000,000 people worldwide and only 400 approved therapies. How can we adapt traditional recruitment strategies to target the right patients? The goal is to create tailored adaptive strategies aimed at extending reach and building relationships. There are many ways in which this can be done. In this first post of a series focused on adaptive recruitment for rare disease, I will explore the introduction of an early support program.

Topics: Patient Recruitment, Rare Disease

Site Selection & Enrollment Feasibility for Global Patient Recruitment

By BBKWorldwide on Tue, May 12, 2015 | 3 min read

While the push for sponsors to go global with clinical studies is old news, the industry has been working hard to develop and invest in ways to choose the right sites and countries. Ultimately, site selection matters because investigator sites are the only place where study volunteers can participate in clinical research. Enrollment is the end game – further drug development, regulatory submissions and marketing are contingent on having this data.

Topics: Patient Recruitment, Site Selection

 
Subscribe To Our Blog